Your browser doesn't support javascript.
loading
Effectiveness and safety of blonanserin in young and middle-aged female patients with schizophrenia: data from a post-marketing surveillance.
Bo, Qijing; Wang, Xijin; Liu, Xuejun; Sang, Hong; Xun, Zhiyuan; Zhang, Ruiling; Yang, Xiaodong; Deng, Huaili; Li, Keqing; Chen, Jindong; Sun, Meijuan; Zhao, Guijun; Liu, Xianglai; Cai, Duanfang; Zhan, Guilai; Li, Juhong; Li, Haiyun; Wang, Gang.
Afiliación
  • Bo Q; The National Clinical Research Center for Mental Disorders & Beijing Key Laboratory of Mental Disorders & Beijing Institute for Brain Disorders Center of Schizophrenia, Beijing Anding Hospital, Capital Medical University, Beijing, 100088, China.
  • Wang X; Department of Psychiatry, The First Psychiatric Hospital of Harbin, Harbin, Heilongjiang, 150010, China.
  • Liu X; Department of Psychiatry, Brain Hospital of Hunan Province, Changsha, Hunan, 410007, China.
  • Sang H; Mental Health Center, Changchun Sixth Hospital, Changchun, Jilin, 130052, China.
  • Xun Z; Department of Psychiatry, Tianjin Anding Hospital, Tianjin, Tianjin, 300222, China.
  • Zhang R; Department of Psychiatry, Henan Mental Hospital, Xinxiang, Henan, 453002, China.
  • Yang X; Department of Psychiatry, Shandong Mental Health Center, Jinan, Shandong, 250014, China.
  • Deng H; Department of Psychology, Psychiatric Hospital of Taiyuan City, Taiyuan, Shanxi, 030000, China.
  • Li K; Department of Psychiatry, Hebei Provincial Mental Health Center, Baoding, Hebei, 071000, China.
  • Chen J; Department of Psychiatry, National Clinical Research Center for Mental Disorders, The Second Xiangya Hospital of Central South University, Changsha, Hunan, 410011, China.
  • Sun M; Department of Pharmacy, Daqing Third Hospital, Daqing, Heilongjiang, 163712, China.
  • Zhao G; Department of Psychiatry, Guangyuan Mental Health Center, Guangyuan, Sichuan, 628001, China.
  • Liu X; Institute of Mental Health, Hainan Provincial Anning Hospital, Haikou, Hainan, 570206, China.
  • Cai D; Department of Psychiatry, The Fifth People's Hospital of Zigong, Zigong, Sichuan, 643020, China.
  • Zhan G; Department of Psychiatry, Xuhui Mental Health center, Shanghai, 200232, China.
  • Li J; Department of Psychiatry, The Fourth People's Hospital of Chengdu, Chengdu, Sichuan, 610036, China.
  • Li H; Medical Affairs, Sumitomo Pharma (Suzhou) Co., Ltd, Shanghai, 200025, China.
  • Wang G; Advanced Innovation Center for Human Brain Protection, Capital Medical University, Beijing, 100088, China. gangwangdocvip@163.com.
BMC Psychiatry ; 23(1): 115, 2023 02 21.
Article en En | MEDLINE | ID: mdl-36810039
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Esquizofrenia / Antipsicóticos Tipo de estudio: Clinical_trials / Guideline / Observational_studies / Risk_factors_studies / Screening_studies Límite: Female / Humans / Middle aged Idioma: En Revista: BMC Psychiatry Asunto de la revista: PSIQUIATRIA Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Esquizofrenia / Antipsicóticos Tipo de estudio: Clinical_trials / Guideline / Observational_studies / Risk_factors_studies / Screening_studies Límite: Female / Humans / Middle aged Idioma: En Revista: BMC Psychiatry Asunto de la revista: PSIQUIATRIA Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: Reino Unido